AlphaStocks

AZN vs FCN

As of Sep 20, 2026, Astrazeneca (AZN) scores 5.0/10 and FTI Consulting (FCN) 4.4/10 on AlphaStocks' five-model composite, so AZN scores higher. AZN trades 14% below its model fair value; FCN trades 33% below its model fair value.

AZN

ASTRAZENECA PLC

5.0

Consider Buy

$166.29

FCN

FTI CONSULTING, INC

4.4

Weak

$141.17

AZN vs FCN: Which is the Better Investment?

ASTRAZENECA PLC (AZN) scores 5.0/10 while FTI CONSULTING, INC (FCN) scores 4.4/10 on AlphaStocks' composite model. ASTRAZENECA PLC has the higher composite rating of Consider Buy. On a P/E basis, FTI CONSULTING, INC trades at 17.1x, making it the more attractively priced of the two. FTI CONSULTING, INC trades further below its estimated fair value.

This comparison is algorithmically generated and is not financial advice.

MetricAZNFCN
Scores & Fundamentals
Composite Score5.0/104.4/10
RatingConsider BuyWeak
Price$166.29$141.17
P/E Ratio25.417.1
ROE21.9%14.5%
Market Cap$260B$4B
Fair Value$192.63$209.99
Dividend Yield1.9%
Sector Rank#111 of 168#161 of 265
Model Verdicts
PiotroskiStrongAttractive
BuffettStrongStrong
GrahamCautionCaution
LynchNeutralNeutral
GreenblattNeutralAttractive
View full AZNanalysis →View full FCNanalysis →

Related comparisons

Compare any two stocks →

AZN vs FCN: Which Stock Scores Higher?

ASTRAZENECA PLC (AZN) is in the Health Care sector; FTI CONSULTING, INC (FCN) is in Industrials. AZN currently leads with a composite score of 5.0/10 (Consider Buy) compared to FCN's 4.4/10 (Weak).

The AlphaStocks composite score evaluates each stock across four dimensions: Quality (business strength measured by Piotroski F-Score and Buffett quality criteria), Value (discount to intrinsic worth using Graham, Lynch, and Greenblatt models), Momentum (6-month price trend), and Timing (a confirmation signal that requires both value and momentum to align). A higher composite score indicates stronger overall fundamentals combined with favorable market conditions.

This comparison uses the same scoring framework for both companies, ensuring an apples-to-apples evaluation. Scores are recalculated daily after market close using data from SEC filings and market prices. Read the full methodology to understand how each model contributes to the composite score.

Scores are algorithm-generated research tools, not investment recommendations. Past performance does not guarantee future results. Always do your own due diligence. Full disclaimer